Susan Hasty, Publisher
Table of Contents . . . October 4th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Gene Therapy Weekly | Other Publications
Gene Dynamics - HLA Class II Alleles Mark Therapeutic Response To Sudden Hearing Loss
Orthopedics - New Vector Could Heal Tendon And Ligament Injuries
Cardiac Disease - Tissue Factor Repressor Inhibits Thrombus Formation In Arteries
HIV Vaccines - Favorable Genetic Factors Same For Progression, Vaccine Efficacy
Preeclampsia - Inherited Thrombophilia Not Linked To Development
Psychology - Pathological Gambling May Be Linked To Genetic Influences
Transgenesis - Researchers Successfully Transplant Reporter Gene Into Rhesus Embryo
Appointments - Cell Genesys Promotes Joseph Vallner To President
Appointments - Genome Therapeutics Elects David K. Stone To Board Of Directors
Biotechnology - Arena Collaborates With TaiGen On Multireceptor CART
Infectious Disease - Genomics System Combats Deadly Bacterial Complications Of AIDS, Cystic Fibrosis
Liver Cancer - Vector Prevents Hepatocellular Carcinoma In Animal Model
Metastases - BioReliance Will Produce Two Anticancer Drugs For MediGene
Prostate Cancer - Antisense Therapy Looks Promising In Animal Model
Prostate Cancer - Co-X-Gene Technology Will Target Advanced, Hormone-Refractory Disease
Ribozyme Therapy - Phase I Clinical Trial For Breast/Ovarian Cancer Initiated
Technology - Lexicon Genetics Grants Gene Targeting License To GlaxoSmithKline
Technology - Motorola Announces New System For Gene Expression Profiling
Therapy - Lexicon Licenses Gene Targeting Technology To Merck
Therapy - TKT Strengthens Technology Base With Patent For Protein Production, Delivery
Tuberculosis Epidemiology - Conventional Contact Tracing Inferior To Genetic Testing For Clusters
Vaccine Therapy - Peptide Immunizations Lower Diabetic Incidence In Animal Model
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.